Pathogenesis of Depression in Alzheimer's Disease

Neurochem Res. 2024 Mar;49(3):548-556. doi: 10.1007/s11064-023-04061-0. Epub 2023 Nov 28.

Abstract

Depression is a prevalent occurrence among Alzheimer's disease (AD) patients, yet its underlying mechanism remains unclear. Recent investigations have revealed that several pathophysiological changes associated with Alzheimer's disease can lead to mood disorders. These alterations include irregularities in monoamine neurotransmitters, disruptions in glutamatergic synaptic transmission, neuro-inflammation, dysfunction within the hypothalamic-pituitary-adrenocortical (HPA) axis, diminished levels of brain-derived neurotrophic factor (BDNF), and hippocampal atrophy. This review consolidates research findings from pertinent fields to elucidate the mechanisms underlying depression in Alzheimer's disease, aiming to provide valuable insights for the study of its mechanisms and clinical treatment.

Keywords: Alzheimer's Disease; BDNF; Depression; Glutamate; HPA axis; Hippocampal atrophy; Neuro-inflammation; Serotonin.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Brain-Derived Neurotrophic Factor
  • Depression
  • Humans
  • Inflammation / complications

Substances

  • Brain-Derived Neurotrophic Factor